About Us
Camargo Pharmaceutical Services - Exerts in 505(b)(2)
Camargo Pharmaceutical Services - Your Drug Development Partner
Camargo Pharmaceutical Services
Camargo's expertise in drug approval will put your product on the fast-track to market. Specializing in the 505(b)(2) pathway globally, our team executes a spectrum of small and large molecule development programs. We provide expert advice grounded in years of industry and regulatory experience to take you from discovery to post-approval marketing, with a full range of services for pharmaceutical and
biotech development teams.
- Cost-effective solutions
- Increase speed-to-market
- Maintain regulatory compliance
We partner with you to develop a comprehensive program while executing every facet of the plan, from formulation and testing the drug product, to conducting clinical studies and preparing FDA submissions- Camargo is by your side through each step.
The Drug Kennel Blog
In the Drug Kennel, Camargo President and CEO Ken Phelps presents answers to commonly asked product development and regulatory questions and provides commentary on recent news/trends in the industry. Use this blog as your go-to reference tool while navigating the drug development landscape.
Add comments, ask questions or share it. You can also subscribe to the Drug Kennel blog to receive updates automatically. Access the blog here.
Camargo Pharmaceutical Services
9825 Kenwood Road, Suite 203
Cincinnati, OH 45242-6521
UNITED STATES
Phone: 888-451-5708
Fax: 513-561-3367
Contact: Rick Bell
- 505(b)(2): Is it for you?
- Pre-Phase I Services
- CMC Strategy and Management (Chemistry, Manufacturing and Control)
- Phase I - IV Clinical Development Services
- Regulatory Consulting and Review
- DESI (Drug Efficacy Study Implementation) Drugs Approval
- Expert In 505(b)(2) To Conduct One-Day Workshop
- Camargo Hires Rick Bell To Lead Business Development
- White Paper: Foreign Clinical Trial Data
- White Paper: Understanding the 505(b)(2) Approval Pathway
- Camargo Expands, Opens New Office In The Research Triangle Park
- Camargo’s Ruth E. Stevens Leads Open Forum At AAPS Annual Meeting
- CMC For 505(b)(2) Applications
- Camargo Presents At The International Conference Of The Korean Society Of Pharmaceutical Services And Technology
- Camargo Recognized As One Of Cincinnati’s 2009 Fast 55
- Camargo Awarded For Regulatory Poster At 2009 AAPS Annual Meeting And Exposition
- Camargo CEO Ken Phelps On PharmaVOICE Top 100 List
- Q&A: Understanding The 505(b)(2) Approval Pathway
- Camargo Adds VP Clinical Development & Chief Medical Officer, Samer E. Kaba, MD
- Camargo Hires Elaine Taylor, Director Of Research Services
- Camargo Hires Lynn Gold, PhD, Vice President Of CMC Services
- Article: The 505(b)(2) Alternative - An NDA that Saves Time and Money
- Case Study: IND Preparation and Submission - Fast-Track Re-Submittal of pre-IND
- Case Study: Pharmacokinetics - Client Wins With Unique Camargo Methodology
- Case Study: Clinical Program Development - Camargo’s Strategic Outsourcing Yields Client Benefits

